Skip to main content

Table 2 Description of the five recurrences

From: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor

  Age at diagnosis FIGO staging Intraoperative/pathologic cyst rupture Approach Kind of operation (none of them had any re-resection) Serum marker at diagnosis Years from first surgery to recurrence Nature of relapses Recurrence site Treatment for relapse Last control status Time of follow-up (years)
1 34.53 IA No LSC Adnexectomy CA199 = 7939 1.4 IOT mucinous intestinal contralateral ovary, IA debulking Free of disease 6.06
Neg washings
CA125 = 4387
2 35.63 IC No / Yes LT Adnexectomy   2 BOT serous contralateral ovary USO + TAH Free of disease 10.14
Neg washings
3 20.30 IC No / Yes LSC Cystectomy   2 BOT mucinous intestinal same ovary debulking Free of disease 5.80
Neg washings
4 62.62 IC Yes LSC Adnexectomy CA125 = 554 6.2 IOT serous pelvic lymph node IIIC debulking + chemotherapy Alive with disease 9.66
Neg washings
5 38.42 IA No LT Adnexectomy   4.7 IOT mucinous intestinal positive ascites, IIC debulking Dead of disease 6.69
   Neg washings           
  1. BOT, borderline ovarian tumor; IOT, invasive ovarian tumor; LSC, laparoscopy; LT, laparotomy; USO + TAH, unilateral oophorectomy plus total abdominal hysterectomy.